Alvotech
News
Alvotech (NASDAQ:ALVO) Short Interest Up 108.1% in August
Ticker Report Alvotech (NASDAQ:ALVO - Get Free Report) saw a large growth in short interest during the month of August. As of August 15th, there was short interest totalling 135,900 shares, a growth of 108.1% from...\n more…
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Globe Newswire REYKJAVIK, Iceland, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients...\n more…
Alvotech Second Quarter 2024 Earnings: EPS: US$0.25 (vs US$0.83 in 2Q 2023)
Simply Wall St Alvotech ( NASDAQ:ALVO ) Second Quarter 2024 Results Key Financial Results Revenue: US$198.8m (up by US$194.3m from 2Q...\n more…
Alvotech's Strong Q2 Performance and Positive Outlook Justify Buy Rating
TipRanks Financial Blog In a report released on August 16, Balaji Prasad from Barclays maintained a Buy rating on Alvotech (ALVO - Research Report), with a price target of...\n more…